JANUX THERAPEUTICS INC (JANX:NASDAQ)
$17.16 0.915 (5.6325%)
Analysed JANUX THERAPEUTICS INC (JANX:NASDAQ) News Sources
Janux Therapeutics (JANX) Is Up 7.1% After Reporting Narrower Net Losses And Improved Earnings Profile
11-08-2026
yahoo.com
JANX Shares Gain 19.1% in 3 Months: Here's What You Need to Know
21-08-2026
yahoo.com
Here Are Monday’s Top Wall Street Analyst Research Calls: AstraZeneca, Celestica, Chipotle Mexican Grill, Domino’s Pizza, Fortune Brands, Golar LNG, Jersey Mike’s Subs, Roku, and More
24-08-2026
247wallst.com
Chipotle downgraded, Darden upgraded: Wall Street's top analyst calls
24-08-2026
yahoo.com
4 Prostate Cancer Drug Stocks to Watch During Awareness Month
15-09-2026
yahoo.com
The Zacks Analyst Blog Highlights Pfizer, Novartis, Candel and Janux
16-09-2026
yahoo.com
Here's Why You Should Add JANX Stock to Your Portfolio Now
26-05-2026
yahoo.com
Janux Therapeutics, Inc. (JANX) Reports Q1 Loss, Lags Revenue Estimates
07-05-2026
yahoo.com
Is Janux Therapeutics, Inc. (JANX) Stock a Biotech Opportunity With Next-Generation Immunotherapy Potential?
30-06-2026
yahoo.com
Janux Therapeutics Announces First Patient Dosed in Phase 1 Study of JANX013
14-09-2026
yahoo.com
What is the current price of JANUX THERAPEUTICS INC (JANX:NASDAQ)?
The current price of JANUX THERAPEUTICS INC (JANX:NASDAQ) is $17.16.
JANUX THERAPEUTICS INC (JANX:NASDAQ) absolute price change since previous trading day?
The absolute price change of JANUX THERAPEUTICS INC (JANX:NASDAQ) since the previous trading day is $0.915.
JANUX THERAPEUTICS INC (JANX:NASDAQ) percentage price change since previous trading day?
The percentage price change of JANUX THERAPEUTICS INC (JANX:NASDAQ) since the previous trading day is 5.6325%.
What is the most recent average sentiment score for JANUX THERAPEUTICS INC (JANX:NASDAQ)?
The most recent average sentiment score for JANUX THERAPEUTICS INC (JANX:NASDAQ) is 63 out of 100.
What is the most recent average sentiment for JANUX THERAPEUTICS INC (JANX:NASDAQ)?
The most recent sentiment for JANUX THERAPEUTICS INC (JANX:NASDAQ) is .
SEC-8K** Filing Available For JANUX THERAPEUTICS INC (JANX:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.